Thus, adding both ASA and low-dose IL-2 to the OCDC-Bev-Cy combinatorial regimen significantly increased total and perforin-expressing CD3+ and CD8+ TILs infiltrations while reducing tumor-infiltrating Treg cells. The gene discussed is IL2; the disease is neoplasm.